Welcome to the New Century Health - Medical Oncology Policies page. Members follow the Medical Policies for the company underwriting or administering their benefit plan. See Frequently Asked Questions: EmblemHealth Oncology Drug Management to learn about the Medical Oncology Program and who these policies apply to.
See also:
You may sort by Date Issued or Title. You may also enter a keyword to search for a policy.
| Title | Download (PDF) |
|---|---|
| Abraxane (nab paclitaxel) | Download (PDF) |
| Adakveo (crizanlizumab) | Download (PDF) |
| Adstiladrin | Download (PDF) |
| Adcetris (brentuximab vedotin) | Download (PDF) |
| Adzynma | Download (PDF) |
| Alimta and Pemfexy | Download (PDF) |
| Aliqopa (copanlisib) | Download (PDF) |
| Antiemetics | Download (PDF) |
| Arranon (nelarabine) | Download (PDF) |
| Arzerra (ofatumumab) | Download (PDF) |
| Aphexda | Download (PDF) |
| Asparlas (calaspargase pegol-mknl) | Download (PDF) |
| Avastin (bevacizumab) and Biosimilars | Download (PDF) |
| Bavencio (avelumab) | Download (PDF) |
| Beleodaq (belinosat) | Download (PDF) |
| Besponsa (inotuzumab ozogamicin) | Download (PDF) |
| Besremi™ (ropeginterferon alfa-2b-nijft) | Download (PDF) |
| Blenrep (belantamab mafodotin-blmf) | Download (PDF) |
| Blincyto (blinatumomab) | Download (PDF) |
| Bone Modifying Agents (Aredia Zometa Xgeva Prolia) | Download (PDF) |
| Cablivi (caplacizumab-yhdp) | Download (PDF) |
| Clolar (clofarabine) | Download (PDF) |
| Columvi | Download (PDF) |
| Cosela (trilaciclib) | Download (PDF) |
| Cyramza (ramucirumab) | Download (PDF) |
| Danyelza (naxitamab-gqgk) | Download (PDF) |
| Darzalex and Darzalex Faspro | Download (PDF) |
| Doxil or Lipodox (liposomal doxorubicin) | Download (PDF) |
| Elahere; | Download (PDF) |
| Elrexfio (elranatamab-bcmm) | Download (PDF) |
| Elzonris (tagraxofusp) | Download (PDF) |
| Empaveli™ (pegcetacoplan) | Download (PDF) |
| Empliciti (elotuzumab) | Download (PDF) |
| Enhertu (fam-trastuzumab deruxtecan-nxki) | Download (PDF) |
| Enjaymo™ (sutimlimab-jome) | Download (PDF) |
| Erbitux (cetuximab) | Download (PDF) |
| Erwinaze and Rylaze (asparaginase Erwinia chrysanthemi and recombinantrywn) | Download (PDF) |
| Erythropoiesis Stimulating Agents (Aranesp, Epogen, Procrit, Retacrit) | Download (PDF) |
| Faslodex (fulvestrant) | Download (PDF) |
| Folotyn (pralatrexate) | Download (PDF) |
| Fusilev (levoleucovorin) | Download (PDF) |
| Fyarro™ (intravenous sirolimus) | Download (PDF) |
| Gamifant (emapalumab-lzsg) | Download (PDF) |
| Gazyva (obinutuzumab) | Download (PDF) |
| Generic Oncology | Download (PDF) |
| Halaven (eribulin) | Download (PDF) |
| Imfinzi (durvalumab) | Download (PDF) |
| Imjudo | Download (PDF) |
| Imlygic (Talimogene Laherparepvec) | Download (PDF) |
| Intravenous Immune Globulin (Aceniv, Panzyga, Bivigam, Carimune, Cuvitru, Gammagard, Gammaplex, Gamunex, Hiqvia, Gammaked, Octagam, Privigen) | Download (PDF) |
| Iressa (gefitinib) | Download (PDF) |
| Istodax (romidepsin) | Download (PDF) |
| Ixempra (ixabepilone) | Download (PDF) |
| Jelmyto (mitomycin for pyelocalyceal instillation) | Download (PDF) |
| Jemperli (dostarlimab-gxly) | Download (PDF) |
| Jevtana (cabazitaxel) | Download (PDF) |
| Kadcyla (ado-trastuzumab emtansine) | Download (PDF) |
| Keytruda (pembrolizumab) | Download (PDF) |
| Kimmtrak™ (tebentafusp-tebn) | Download (PDF) |
| Kyprolis (carfilzomib) | Download (PDF) |
| LHRH (Agonists and antagonist) | Download (PDF) |
| Libtayo (cemiplimab-rwlc) | Download (PDF) |
| Loqtorzi | Download (PDF) |
| Lumoxiti (moxetumomab pasudotox) | Download (PDF) |
| Lunsumio | Download (PDF) |
| Margenza (margetuximab-cmkb) | Download (PDF) |
| Marqibo (vincristine liposome) | Download (PDF) |
| Myeloid Growth Factors (Fulphila, Granix, Leukine, Neulasta, Neupogen, Nivestym, Nyvepria, Udenyca and Zarxio) | Download (PDF) |
| Monjuvi (tafasitamab-cxix) | Download (PDF) |
| Mozobil™ (plerixafor) | Download (PDF) |
| Mylotarg (gemtuzumab ozogamicin) | Download (PDF) |
| Nplate (romiplostim) | Download (PDF) |
| Onivyde (irinotecan liposome) | Download (PDF) |
| Oncaspar (pegaspargase) | Download (PDF) |
| Opdualag™ (nivolumab and relatlimab-rmbw) | Download (PDF) |
| Opdivo (nivolumab) | Download (PDF) |
| Padcev (enfortumab vedotin-ejfv) | Download (PDF) |
| Pedmark (sodium thiosulfate) | Download (PDF) |
| Pepaxto (melphalan flufenamide) | Download (PDF) |
| Photofrin (porfimer) | Download (PDF) |
| Polivy (polatuzumab vedotin) | Download (PDF) |
| Poteligeo (mogamulizumab-kpkc) | Download (PDF) |
| Provenge (sipuleucel-T) | Download (PDF) |
| Reblozyl (luspatercept-aamt) | Download (PDF) |
| Rituximab Products (Riabni, Rituxan Hyclea, Ruxience, Truxima) | Download (PDF) |
| Rybrevant™ (amivantamab-vmjw) | Download (PDF) |
| Sarclisa (isatuximab-irfc) | Download (PDF) |
| Soliris (eculizumab) | Download (PDF) |
| Somatostatin Analog | Download (PDF) |
| Sylvant (siltuximab) | Download (PDF) |
| Synribo (omacetaxine) | Download (PDF) |
| Talvey (talquetamab-tgvs) | Download (PDF) |
| Tecentriq (atezolizumab) | Download (PDF) |
| Tecvayli | Download (PDF) |
| Tepadina (thiotepa) | Download (PDF) |
| Torisel (temsirolimus) | Download (PDF) |
| Tivdak™ (tisotumab vedotin-tftv) | Download (PDF) |
| Trastuzumab Products and Phesgo (pertuzumab trastuzumab and hyaluronidase-zzxf) Herceptin, Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera | Download (PDF) |
| Treanda_Bendeka_Belrapzo (bendamustine) | Download (PDF) |
| Trisenox (arsenic trioxide) | Download (PDF) |
| Trodelvy (sacituzumab govitecan-hziy) | Download (PDF) |
| Ultomiris (ravulizumab) | Download (PDF) |
| Unituxin (dinutuximab) | Download (PDF) |
| Valstar (valrubicin) | Download (PDF) |
| Vectibix (panitumumab) | Download (PDF) |
| Velcade (bortezomib) | Download (PDF) |
| Vyxeos (daunorubicin and cytarabine liposomal) | Download (PDF) |
| Yervoy (ipilimumab) | Download (PDF) |
| Yondelis (trabectedin) | Download (PDF) |
| Zaltrap (ziv-aflibercept) | Download (PDF) |
| Zepzelca (lurbinectedin) | Download (PDF) |
| Zynlonta (loncastuzimab tesirine-lpyl) | Download (PDF) |
| Zynyz (retifanlimab-dlwr) | Download (PDF) |
JP58657:08/22
